 CinCor Pharma Inc. CINC, is set to go public on the Nasdaq Friday, after the Massachusetts-based biopharmaceutical companys upsized initial public offering priced overnight at 16 a share, in the middle of the expected range of between 15 and 17 a share. The company raised 193.6 million as it sold 12.1 million shares in the IPO, up from previous expectations of an 11.0 million share offering. 